Opinion Pieces

2026

A Potential Blessing in Disguise for Pharma, Financial Express, 31 July 2026.

Will Reforming BITs Revive FDI Inflows?, Financial Express, 22 June 2026.

India-Korea Partnership Needs Deeper Engagement, Business Line, 16 May 2026.

Biopharma Strategy Needs Regulatory Focus, Financial Express, 20 February 2026.

Make in India to Transform India’s Pharmaceutical Sector, Optima, Issue 13, The Annual Outlook, Department of Economics, Daulat Ram College, University of Delhi, pp. 32–35, 2026.

2025

A New Leader in Pharma, Times of India, 29 June 2025.

Trump’s Reciprocal Tariff Policy: Implications for Indian Pharma Industry, India’s World: International Affairs-Indian Interests, 26 March 2025.

2024

Pharma PLI Needs to Be Revisited, Business Line, 30 April 2024.

2023

Can Deep-Tech Start-Ups Propel Drug Discovery?, BioSpectrum, November 2023.

The Way Ahead for Innovation in India, Business Line, 30 October 2023.

India’s R&D Estimates Are an Incomplete Picture, The Hindu, 24 February 2023.

2022

The Curious Case of India’s Rising Trade Deficit with China in Pharmaceuticals, Express Pharma, 17(11), October 2022.

Connecting the Dots to Boost the Patent Ecosystem, The Hindu, 14 September 2022.

Petty Patents Can Boost R&D, The Hindu, 20 June 2022.

Innovation in India’s Pharma Sector Matters to the World. Here’s Why, Moneycontrol.com, 15 March 2022.

India to Be Self-Sufficient in Pharmaceutical Ingredients: Listen to Dr. Reji K Joseph in ISID, The Chemical Daily, Japan, 8 March 2022. (Interview)

A Self-Reliant Pharma Industry, The Hindu, 8 February 2022. (Co-author)

2021

Only a Global Effort Can Tame Covid-19, The Hindu, 31 May 2021. (Co-author)

No to Vaccine Nationalism, Yes to Global Cooperation, The Hindu, 4 February 2021. (Co-author)

2020

Reducing the API Dependence: Have We Got the Strategy Right?, TISA, Vol. 10, Issue VI (Annual Special Issue), Chamber of Small Industry Associations, pp. 68–75, December 2020.

Reducing API Dependence: Have We Got the Strategy Right?, Express Pharma, 2 November 2020.

Indian Pharma is Being Squeezed – and It’s Bad News for Drug Access in Developing Countries, The Conversation, 30 October 2020. (Co-author)

Crouching Dragon: Chinese Influence Set to Rise in the Post-Covid Global Economy, Policy Circle, 10 June 2020.

Big Opportunity for India, Down To Earth, 1–15 May 2020.

US Tries to Thwart TRIPS Flexibilities in the Midst of a Pandemic, LiveMint, 1 May 2020.

Covid-19 Exposes India’s Dependence on China for Active Pharmaceutical Ingredients, Down To Earth, 7 April 2020. (Quoted)

Drug Pricing is Certainly Not the Issue in Growing Dependence on China, Financial Express, 6 April 2020.

Reducing India’s Import Dependence on APIs: A Possible Way Out, Express Pharma, 31 March 2020.

Challenges in Promoting Bilateral Trade in Pharmaceuticals between India and Pakistan, Regional Prosperity in South Asia, Policy Brief, Chao Track, 2020.

2019

Revamping the Indian Start-up Ecosystem, Financial Express, 12 December 2019.

India’s Challenges in the Global Landscape of Start-Up Ecosystem, Global South Colloquy, 2 December 2019.

As Modi Visits US, What Does the Free Trade Pact Mean for India’s Pharma Industry?, The Wire, 21 September 2019.

Global Innovation Index: Key Takeaways for India, Expert Speak, Observer Research Foundation, 30 August 2019.

Mike Pompeo’s Visit and the Tussle Over Data Localization, LiveMint, 20 June 2019.

Is Technology Driving the US-China Trade War?, Global South Colloquy, 19 June 2019.

Special 301 Report 2019: A Deliberate Attempt to Weaken India’s Patents Act and to Tarnish Indian Generic Pharmaceutical Industry, Express Pharma, 1 May 2019.

2018

Investment Facilitation: New Dynamism at WTO on Investment, Columbia FDI Perspectives No. 235, Columbia Center on Sustainable Investment, 24 September 2018.

2017

Draft Pharmaceutical Policy 2017: Needs More Clarity and Clear Road Maps, ET Healthworld, 31 August 2017.

2016

Compulsory Licenses Needed in India to Ensure Affordable Medicines, The Wire, 7 May 2016.

2008

The Ranbaxy Model and Consolidation in Pharma Sector, Economic Times, 24 June 2008.